<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                Part 312: Investigational New Drug Application
                            </h3>
                            <table>
  <thead>
    <tr>
      <th scope="col">Section No.</th>
      <th scope="col">Description</th>
    </tr>
  </thead>
  <tbody>
    
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.1.html">
                        Section 312.1
                        </a>
                  </td>
                  <td scope="row">Scope</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.2.html">
                        Section 312.2
                        </a>
                  </td>
                  <td scope="row">Applicability</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.3.html">
                        Section 312.3
                        </a>
                  </td>
                  <td scope="row">Definitions and interpretations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.6.html">
                        Section 312.6
                        </a>
                  </td>
                  <td scope="row">Labeling of an investigational new drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.7.html">
                        Section 312.7
                        </a>
                  </td>
                  <td scope="row">Promotion of investigational drugs</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.8.html">
                        Section 312.8
                        </a>
                  </td>
                  <td scope="row">Charging for investigational drugs under an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.10.html">
                        Section 312.10
                        </a>
                  </td>
                  <td scope="row">Waivers</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.20.html">
                        Section 312.20
                        </a>
                  </td>
                  <td scope="row">Requirement for an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.21.html">
                        Section 312.21
                        </a>
                  </td>
                  <td scope="row">Phases of an investigation</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.22.html">
                        Section 312.22
                        </a>
                  </td>
                  <td scope="row">General principles of the IND submission</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.23.html">
                        Section 312.23
                        </a>
                  </td>
                  <td scope="row">IND content and format</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.30.html">
                        Section 312.30
                        </a>
                  </td>
                  <td scope="row">Protocol amendments</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.31.html">
                        Section 312.31
                        </a>
                  </td>
                  <td scope="row">Information amendments</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.32.html">
                        Section 312.32
                        </a>
                  </td>
                  <td scope="row">IND safety reporting</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.33.html">
                        Section 312.33
                        </a>
                  </td>
                  <td scope="row">Annual reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.38.html">
                        Section 312.38
                        </a>
                  </td>
                  <td scope="row">Withdrawal of an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.40.html">
                        Section 312.40
                        </a>
                  </td>
                  <td scope="row">General requirements for use of an investigational new drug in a clinical investigation</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.41.html">
                        Section 312.41
                        </a>
                  </td>
                  <td scope="row">Comment and advice on an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.42.html">
                        Section 312.42
                        </a>
                  </td>
                  <td scope="row">Clinical holds and requests for modification</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.44.html">
                        Section 312.44
                        </a>
                  </td>
                  <td scope="row">Termination</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.45.html">
                        Section 312.45
                        </a>
                  </td>
                  <td scope="row">Inactive status</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.47.html">
                        Section 312.47
                        </a>
                  </td>
                  <td scope="row">Meetings</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.48.html">
                        Section 312.48
                        </a>
                  </td>
                  <td scope="row">Dispute resolution</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.50.html">
                        Section 312.50
                        </a>
                  </td>
                  <td scope="row">General responsibilities of sponsors</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.52.html">
                        Section 312.52
                        </a>
                  </td>
                  <td scope="row">Transfer of obligations to a contract research organization</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.53.html">
                        Section 312.53
                        </a>
                  </td>
                  <td scope="row">Selecting investigators and monitors</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.54.html">
                        Section 312.54
                        </a>
                  </td>
                  <td scope="row">Emergency research under Sec</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.55.html">
                        Section 312.55
                        </a>
                  </td>
                  <td scope="row">Informing investigators</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.56.html">
                        Section 312.56
                        </a>
                  </td>
                  <td scope="row">Review of ongoing investigations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.57.html">
                        Section 312.57
                        </a>
                  </td>
                  <td scope="row">Recordkeeping and record retention</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.58.html">
                        Section 312.58
                        </a>
                  </td>
                  <td scope="row">Inspection of sponsor's records and reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.59.html">
                        Section 312.59
                        </a>
                  </td>
                  <td scope="row">Disposition of unused supply of investigational drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.60.html">
                        Section 312.60
                        </a>
                  </td>
                  <td scope="row">General responsibilities of investigators</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.61.html">
                        Section 312.61
                        </a>
                  </td>
                  <td scope="row">Control of the investigational drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.62.html">
                        Section 312.62
                        </a>
                  </td>
                  <td scope="row">Investigator recordkeeping and record retention</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.64.html">
                        Section 312.64
                        </a>
                  </td>
                  <td scope="row">Investigator reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.66.html">
                        Section 312.66
                        </a>
                  </td>
                  <td scope="row">Assurance of IRB review</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.68.html">
                        Section 312.68
                        </a>
                  </td>
                  <td scope="row">Inspection of investigator's records and reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.69.html">
                        Section 312.69
                        </a>
                  </td>
                  <td scope="row">Handling of controlled substances</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.70.html">
                        Section 312.70
                        </a>
                  </td>
                  <td scope="row">Disqualification of a clinical investigator</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.80.html">
                        Section 312.80
                        </a>
                  </td>
                  <td scope="row">Purpose</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.81.html">
                        Section 312.81
                        </a>
                  </td>
                  <td scope="row">Scope</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.82.html">
                        Section 312.82
                        </a>
                  </td>
                  <td scope="row">Early consultation</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.83.html">
                        Section 312.83
                        </a>
                  </td>
                  <td scope="row">Treatment protocols</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.84.html">
                        Section 312.84
                        </a>
                  </td>
                  <td scope="row">Risk-benefit analysis in review of marketing applications for drugs to treat life-threatening and severely-debilitating illnesses</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.85.html">
                        Section 312.85
                        </a>
                  </td>
                  <td scope="row">Phase 4 studies</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.86.html">
                        Section 312.86
                        </a>
                  </td>
                  <td scope="row">Focused FDA regulatory research</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.87.html">
                        Section 312.87
                        </a>
                  </td>
                  <td scope="row">Active monitoring of conduct and evaluation of clinical trials</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.88.html">
                        Section 312.88
                        </a>
                  </td>
                  <td scope="row">Safeguards for patient safety</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.110.html">
                        Section 312.110
                        </a>
                  </td>
                  <td scope="row">Import and export requirements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.120.html">
                        Section 312.120
                        </a>
                  </td>
                  <td scope="row">Foreign clinical studies not conducted under an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.130.html">
                        Section 312.130
                        </a>
                  </td>
                  <td scope="row">Availability for public disclosure of data and information in an IND</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.140.html">
                        Section 312.140
                        </a>
                  </td>
                  <td scope="row">Address for correspondence</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.145.html">
                        Section 312.145
                        </a>
                  </td>
                  <td scope="row">Guidance documents</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.160.html">
                        Section 312.160
                        </a>
                  </td>
                  <td scope="row">Drugs for investigational use in laboratory research animals or in vitro tests</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.300.html">
                        Section 312.300
                        </a>
                  </td>
                  <td scope="row">General</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.305.html">
                        Section 312.305
                        </a>
                  </td>
                  <td scope="row">Requirements for all expanded access uses</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.310.html">
                        Section 312.310
                        </a>
                  </td>
                  <td scope="row">Individual patients, including for emergency use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.315.html">
                        Section 312.315
                        </a>
                  </td>
                  <td scope="row">Intermediate-size patient populations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR312.320.html">
                        Section 312.320
                        </a>
                  </td>
                  <td scope="row">Treatment IND or treatment protocol</td>
                </tr>
                
  </tbody>
</table>

      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
